The following six publications posted here are given out by the Bing Center. They can be beneficial to patient and caregivers. Topics include genomics, treatment options, latest information on ibrutinib, Bing Neel Syndrome, National Comprehensive Cancer Network guidelines for WM booklet and two articles from the 8th International Workshop on WM.
2. Ibrutinib for patients with rituximab-refractory
Waldenström’s macro globulinaemia (iNNOVATE):
an open-label substudy of an international, multicentre,
phase 3 trial